During the past decade, Kochi Medical School Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 9 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kochi Medical School Hospital" #1 sponsor was "Loxo Oncology, Inc." with 5 trials, followed by "Kochi University" with 4 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kochi Medical School Hospital" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Boehringer Ingelheim" with 2 trials as a collaborator, "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Eidos Therapeutics, a BridgeBio company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Kochi Medical School Hospital" are "Chronic Lymphocytic Leukemia" (4 trials), "Small Lymphocytic Lymphoma" (4 trials), "Axial Spondyloarthritis" (2 trials), "Colorectal Cancer" (2 trials) and "Gastrointestinal Stromal Tumor" (2 trials). Many other conditions were trialed in "Kochi Medical School Hospital" in a lesser frequency.

Most popular intervention types in "Kochi Medical School Hospital" are "Drug" (29 trials), "Other" (2 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Rituximab" (5 trials), "Pirtobrutinib" (4 trials), "Abiraterone" (2 trials) and "Apremilast" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kochi Medical School Hospital" are 35 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kochi Medical School Hospital". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Kochi Medical School Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kochi Medical School Hospital, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".